“The income from operations, however, increased by around 15% to Rs 1621.1 crore from Rs 1401.4 crore in the corresponding period last fiscal,” Cadila Healthcare said in a statement.
The operating profit margins contracted by 349bps to end the quarter at 13.6% due to higher rise in the R&D and other expenditure.
The company’s total raw material cost in Q3 increased by 60% to Rs 398 crore, while tax payment surged by almost four-fold to Rs 63 crore over the previous year quarter.
The stock opened at Rs 780 and hit a low of Rs 720 on NSE. As many as a combined 182,615 shares have already changed hands on the counter in morning deals against an average 160,000 shares that were traded daily in past two weeks on NSE and BSE
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
